Protalix BioTherapeutics, Inc. (PLX) Net income 2016–2025
Protalix BioTherapeutics, Inc. (PLX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.6MFY2025 · since FY2016: -$29.4M → -$6.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.6M | -325.2% |
| FY2024 | $2.9M | -64.7% |
| FY2023 | $8.3M | +155.7% |
| FY2022 | -$14.9M | +45.9% |
| FY2021 | -$27.6M | -322.8% |
| FY2020 | -$6.5M | +64.3% |
| FY2019 | -$18.3M | +30.9% |
| FY2018 | -$26.5M | +68.3% |
| FY2017 | -$83.4M | -184.1% |
| FY2016 | -$29.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice